Francesca Prignano

Summary

Affiliation: University of Florence
Country: Italy

Publications

  1. ncbi request reprint Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis
    F Prignano
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    Int J Immunopathol Pharmacol 22:379-87. 2009
  2. doi request reprint Tuberculosis reactivation risk in dermatology
    Leonardo Pescitelli
    Address correspondence to Dr Prignano, Division of Clinical, Preventive and Oncology Dermatology, Department of Surgery and Translational Medicine, Florence University, Ospedale Piero Palagi, v le Michelangelo 41, 50125 Florence, Italy E mail
    J Rheumatol Suppl 91:65-70. 2014
  3. pmc Itch in psoriasis: epidemiology, clinical aspects and treatment options
    F Prignano
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    Clin Cosmet Investig Dermatol 2:9-13. 2009
  4. doi request reprint Development of MGUS in psoriatic patients: a possible undiagnosed event during anti-TNF-α-treatment
    F Prignano
    Department of Dermatological Sciences, Florence University, Santa Maria Annunziata Hospital, Florence, Italy
    J Eur Acad Dermatol Venereol 26:1444-8. 2012
  5. doi request reprint Induction of apoptosis by fractional CO2 laser treatment
    Francesca Prignano
    Division of Clinical, Preventive and Oncology Dermatology, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
    J Cosmet Laser Ther 14:267-71. 2012
  6. doi request reprint Why is Kikuchi-Fujimoto disease misleading?
    Francesca Prignano
    Department of Dermatological Sciences University of Florence, Piazza dell Indipendenza, Florence, Italy
    Int J Dermatol 51:564-7. 2012
  7. ncbi request reprint Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients
    Francesca Prignano
    Departmentof Dermatological Sciences, University of Firenze, Firenze, Italy
    Acta Biomed 80:51-6. 2009
  8. doi request reprint Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients
    F Prignano
    Division of Dermatology II, Department of Critical Care Medicine and Surgery, Florence University, Villa S Chiara, Italy
    Br J Dermatol 164:645-7. 2011
  9. ncbi request reprint A global approach to psoriatic patients through PASI score and Skindex-29
    F Prignano
    Department of Critical Care Medicine and Surgery, Division of Clinical, Preventive and Oncologic DermatologyUniversity of Florence, Florence, Italy
    G Ital Dermatol Venereol 146:47-52. 2011
  10. doi request reprint Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin
    Francesca Prignano
    Division of Clinical, Preventive and Oncology Dermatology, Department of Critical Care Medicine and Surgery, University of Florence, Italy
    Arch Dermatol Res 303:231-8. 2011

Collaborators

Detail Information

Publications38

  1. ncbi request reprint Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis
    F Prignano
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    Int J Immunopathol Pharmacol 22:379-87. 2009
    ....
  2. doi request reprint Tuberculosis reactivation risk in dermatology
    Leonardo Pescitelli
    Address correspondence to Dr Prignano, Division of Clinical, Preventive and Oncology Dermatology, Department of Surgery and Translational Medicine, Florence University, Ospedale Piero Palagi, v le Michelangelo 41, 50125 Florence, Italy E mail
    J Rheumatol Suppl 91:65-70. 2014
    ..One could argue that etanercept should be the first choice of anti-TNF agent in populations at high risk of TB. Risk of TB reactivation during treatment with other biologics is not yet well defined. ..
  3. pmc Itch in psoriasis: epidemiology, clinical aspects and treatment options
    F Prignano
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    Clin Cosmet Investig Dermatol 2:9-13. 2009
    ..Pruritus is an important symptom in psoriasis vulgaris, may be severe and seriously affect the quality of life of patients, but published data on its frequency and characteristics are limited...
  4. doi request reprint Development of MGUS in psoriatic patients: a possible undiagnosed event during anti-TNF-α-treatment
    F Prignano
    Department of Dermatological Sciences, Florence University, Santa Maria Annunziata Hospital, Florence, Italy
    J Eur Acad Dermatol Venereol 26:1444-8. 2012
    ....
  5. doi request reprint Induction of apoptosis by fractional CO2 laser treatment
    Francesca Prignano
    Division of Clinical, Preventive and Oncology Dermatology, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
    J Cosmet Laser Ther 14:267-71. 2012
    ..Moreover, we have analyzed if there is a correlation with clinical improvement...
  6. doi request reprint Why is Kikuchi-Fujimoto disease misleading?
    Francesca Prignano
    Department of Dermatological Sciences University of Florence, Piazza dell Indipendenza, Florence, Italy
    Int J Dermatol 51:564-7. 2012
    ..KFD has also been frequently reported in association with systemic lupus erythematosus (SLE)...
  7. ncbi request reprint Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients
    Francesca Prignano
    Departmentof Dermatological Sciences, University of Firenze, Firenze, Italy
    Acta Biomed 80:51-6. 2009
    ..0001). These results proved that tacalcitol treatment is effective in increasing the time interval in consecutive phototherapy cycles and in reducing the total amount of UV exposure...
  8. doi request reprint Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients
    F Prignano
    Division of Dermatology II, Department of Critical Care Medicine and Surgery, Florence University, Villa S Chiara, Italy
    Br J Dermatol 164:645-7. 2011
    ....
  9. ncbi request reprint A global approach to psoriatic patients through PASI score and Skindex-29
    F Prignano
    Department of Critical Care Medicine and Surgery, Division of Clinical, Preventive and Oncologic DermatologyUniversity of Florence, Florence, Italy
    G Ital Dermatol Venereol 146:47-52. 2011
    ..Our objective is to determine the clinical severity of psoriasis and its impact on QoL in patients treated with phototherapy, traditional systemic therapy and biological therapy...
  10. doi request reprint Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin
    Francesca Prignano
    Division of Clinical, Preventive and Oncology Dermatology, Department of Critical Care Medicine and Surgery, University of Florence, Italy
    Arch Dermatol Res 303:231-8. 2011
    ..This study underlines the importance of dendritic cells, Langerhans cells in particular, in non-segmental vitiligo, in its pathogenesis and in its better therapeutical approach...
  11. ncbi request reprint Exacerbation of allergic contact dermatitis during immunosuppression with cyclosporine A
    F Prignano
    Interuniversitary Center of Biologic and Psychosomatic Dermatology, University of Florence, Florence, Italy
    G Ital Dermatol Venereol 145:543-6. 2010
    ..Nevertheless, the control of chronic ACD is often difficult, overall in patients with chronic ACD...
  12. doi request reprint Juvenile psoriatic arthritis and comorbidities: report of a case associated with enthesitis and celiac disease
    F Prignano
    Departement of Dermatological Science, University of Florence, Italy
    Dermatol Ther 23:S47-50. 2010
    ..Cooperation between dermatologists and rheumatologist is mandatory in similar cases, where sophisticated technology and teams with specialized and integrated knowledge are required...
  13. doi request reprint Fractional CO2 laser: a novel therapeutic device upon photobiomodulation of tissue remodeling and cytokine pathway of tissue repair
    F Prignano
    Department of Dermatological Sciences, Florence University, Florence, Italy
    Dermatol Ther 22:S8-15. 2009
    ..07, 2.77, and 4.15 J/cm(2), indicating fractional CO(2) laser as a valuable tool in photorejuvenation with good clinical results, rapid downtime, and an excellent safety profile...
  14. doi request reprint Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities
    F Prignano
    Department of Dermatological Science, University of Florence, Florence, Italy
    J Eur Acad Dermatol Venereol 24:555-60. 2010
    ..Psoriasis is a chronic inflammatory skin condition associated with several risk factors and comorbidities...
  15. doi request reprint Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies
    F Prignano
    Department of Dermatological Sciences, Physiotherapy Unit, Firenze, Italy
    Curr Med Res Opin 25:2311-6. 2009
    ....
  16. doi request reprint Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report
    F Prignano
    University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, Italy
    Dermatol Ther 22:386-90. 2009
    ..When etenarcept became ineffective, he received efalizumab, with a good control of his dermatological condition and a reduction of the viral load...
  17. doi request reprint Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin
    Francesca Prignano
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    J Dermatol Sci 54:157-67. 2009
    ..Recent experimental data underline the complex interactions that exist between melanocytes and other cells found in the skin...
  18. doi request reprint The involvement of Smac/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: Protective effects of curcumin and capsaicin
    Matteo Becatti
    Department of Biochemical Sciences, University of Florence, Italy
    Antioxid Redox Signal 13:1309-21. 2010
    ..These results suggest that antioxidants might represent an alternative approach to protect against vitiligo progression...
  19. doi request reprint Psoriasis and body mass index
    Jana Hercogova
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    Dermatol Ther 23:152-4. 2010
    ..Consequently, the approach of the experienced dermatologist will take into account all the aspects of the patient clinical conditions including the analysis of BMI for the choice of the best suitable therapy...
  20. ncbi request reprint New and experimental treatments of vitiligo and other hypomelanoses
    Torello Lotti
    Department of Dermatological Sciences, University of Florence, Via Lorenzo il Magnifico, 104, 50129, Florence, Italy
    Dermatol Clin 25:393-400, ix. 2007
    ....
  21. doi request reprint A study of fractional CO₂ laser resurfacing: the best fluences through a clinical, histological, and ultrastructural evaluation
    Francesca Prignano
    Departement of Dermatological Sciences, Florence University, Florence, Italy
    J Cosmet Dermatol 10:210-6. 2011
    ....
  22. doi request reprint Efalizumab in the treatment of psoriasis: when comorbidity is an issue
    Francesca Prignano
    Department of Dermatological Sciences, Florence University, Florence, Italy
    Dermatol Ther 21:S25-9. 2008
    ..The current authors present some cases of psoriatic patients with comorbidities successfully treated with efalizumab, an anti-T lymphocyte biological...
  23. pmc SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival
    Matteo Becatti
    Department of Biochemical Sciences, University of Florence, Florence, Italy
    J Cell Mol Med 18:514-29. 2014
    ..We therefore propose SIRT1 activation as a novel way of protecting perilesional vitiligo keratinocytes from damage. ..
  24. doi request reprint Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin?
    Francesca Prignano
    Department of Dermatological Sciences, Florence University, Florence
    J Electron Microsc (Tokyo) 57:25-31. 2008
    ..The vitiligo lesions in the patient's young daughter question the VKH inheritability...
  25. doi request reprint A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 Phototherapy
    Linda Lazzeri
    Section of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy
    Pediatr Dermatol 33:e99-102. 2016
    ....
  26. ncbi request reprint Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity
    Francesca Bandinelli
    Department of Internal Medicine, University of Florence, Italy
    Clin Exp Rheumatol 31:219-24. 2013
    ..The aim of the present study is to investigate using ultrasound (US), lower limb entheseal abnormalities in patients with early psoriatic arthritis (ePsA) and to evaluate their correlation with ePsA clinical characteristics...
  27. doi request reprint The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?
    Torello Lotti
    Department of Dermatological Sciences, Florence University School of Medicine, Florence, Italy
    Dermatol Ther 23:119-22. 2010
    ....
  28. doi request reprint Unusual presentation of tuberculosis in an infliximab-treated patient--which is the correct TB screening before starting a biologic?
    Alessia Gori
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    Dermatol Ther 23:S1-3. 2010
    ..tuberculosis including both tuberculin skin test (TST) and chest X-ray, developed after 4 months of infliximab treatment, a severe pulmonary, lymphnodal and intestinal tuberculosis during infliximab treatment...
  29. ncbi request reprint Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
    Silvia Moretti
    2nd Dermatology Clinic, Department of Dermatological Sciences, University of Florence, Florence, Italy
    J Cutan Pathol 34:301-8. 2007
    ..It is not clear why melanocyte disappearance occurs without fibrotic evolution in halo nevus and with fibrotic evolution in regressing melanoma...
  30. ncbi request reprint Ultrasonographic wrist and hand abnormalities in early psoriatic arthritis patients: correlation with clinical, dermatological, serological and genetic indices
    Francesca Bandinelli
    Division of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
    Clin Exp Rheumatol 33:330-5. 2015
    ....
  31. ncbi request reprint Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha
    Gianni Gerlini
    Plastic Surgery Unit, Regional Melanoma Referral Center, Tuscan Tumor Institute ITT, Santa Maria Annunziata Hospital, Florence, Italy
    J Immunol 181:2999-3008. 2008
    ..The present findings suggest that IFN-alpha alone promptly generates nondendritic APCs able to stimulate memory immune responses. This may represent an additional mode of action of IFN-alpha in vivo...
  32. doi request reprint Prurigo nodularis and lichen simplex chronicus
    Torello Lotti
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    Dermatol Ther 21:42-6. 2008
    ..As psychosomatic factors have been estimated to be present in at least one-third of dermatologic patients, effective management of skin conditions involves consideration of the associated emotional factors...
  33. doi request reprint Fissured tongue responding to biologics during the treatment of psoriasis: the importance of detecting oral involvement of psoriasis
    Angelo Massimiliano D'Erme
    Division of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy
    Dermatol Ther 26:364-6. 2013
    ..The authors think it would be important to consider possible oral lesions in patients suffering from psoriasis in normal practice and to evaluate them introducing specific clinical scales. ..
  34. pmc Efalizumab-induced severe thrombocytopenia can be resolved
    Francesca Prignano
    University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, Italy
    Biologics 2:923-7. 2008
    ..The peculiarity of our case is the absence of signs and symptoms linked to thrombocytopenia and the quick return to normal platelet count without corticosteroid therapy...
  35. ncbi request reprint Therapeutical approaches in melasma
    Francesca Prignano
    Department of Dermatological Science, University of Florence School of Medicine, via Lorenzo di Magnifico, 104, 50129 Florence, Italy
    Dermatol Clin 25:337-42, viii. 2007
    ....
  36. doi request reprint Tumor necrosis factor-alpha and interleukin-17 differently affects Langerhans cell distribution and activation in an innovative three-dimensional model of normal human skin
    Francesca Prignano
    Department of Surgery and Translational Medicine, Section of Clinical Preventive and Oncology Dermatology, Universita di Firenze, 50125 Florence, Italy
    Eur J Cell Biol 94:71-7. 2015
    ....
  37. doi request reprint Sequential effects of photodynamic treatment of basal cell carcinoma
    Francesca Prignano
    Department of Dermatological Sciences, University of Florence, Florence, Italy
    J Cutan Pathol 36:409-16. 2009
    ..Photodynamic therapy (PDT) of superficial basal cell carcinoma (SBCC) acts as a biological response modifier or killing target cells, but sequential biological effects have not been reported in depth in humans...
  38. ncbi request reprint Stem cell factor affects tumour progression markers in metastatic melanoma cells
    Francesca Prignano
    The first Dermatology Clinic, Department of Dermatological Sciences, University of Florence, Florence, Italy
    Clin Exp Metastasis 23:177-86. 2006
    ..Taken altogether these data stress the biological activity of SCF as a cytokine which is able to maintain MMC in a well differentiated status, and suggest a more in depth evaluation of possible effects of SCF on melanoma cells...